Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s stock price passed below its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of GBX 0.11 and traded as low as GBX 0.10. Oxford BioDynamics shares last traded at GBX 0.10, with a volume of 15,910,690 shares changing hands.
Oxford BioDynamics Stock Up 1.9%
The company has a market capitalization of £14.52 million, a price-to-earnings ratio of -0.54 and a beta of 0.42. The company has a current ratio of 2.01, a quick ratio of 2.80 and a debt-to-equity ratio of 131.61. The firm’s 50 day simple moving average is GBX 0.11 and its 200-day simple moving average is GBX 0.18.
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Articles
- Five stocks we like better than Oxford BioDynamics
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
